Molecular cloning, functional expression and chromosomal localization of an amiloride-sensitive Na+ channel from human small intestine  by Schaefer, Lionel et al.
Molecular cloning, functional expression and chromosomal localization
of an amiloride-sensitive Na channel from human small intestine
Lionel Schaefera, Hideki Sakaia, Marie-Genevie've Matteib, Michel Lazdunskia;*,
Eric Linguegliaa
aInstitut de Pharmacologie Mole¤culaire et Cellulaire, CNRS-UPR 411, 660 route des Lucioles, Sophia Antipolis, 06560 Valbonne, France
bINSERM U491, 27, Boulevard Jean Moulin, 13385 Marseille Cedex, France
Received 24 February 2000; received in revised form 17 March 2000
Edited by Pierre Jolles
Abstract Amiloride-sensitive Na+ channels belonging to the
recently discovered NaC/DEG family of genes have been found in
several human tissues including epithelia and central and
peripheral neurons. We describe here the molecular cloning of
a cDNA encoding a novel human amiloride-sensitive Na+
channel subunit that is principally expressed in the small
intestine and has been called hINaC (human intestine Na+
channel). This protein is similar to the recently identified rodent
channel BLINaC and is relatively close to the acid sensing ion
channels (ASICs) (79 and 29% amino acid identity, respectively).
ASICs are activated by extracellular protons and probably
participate in sensory neurons to nociception linked to tissue
acidosis. hINaC is not activated by lowering the external pH but
gain-of-function mutations can be introduced and reveal when
expressed in Xenopus oocytes, an important Na+ channel activity
which is blocked by amiloride (IC50 = 0.5 WM). These results
suggest the existence of a still unknown physiological activator
for hINaC (e.g. an extracellular ligand). The presence of this new
amiloride-sensitive Na+ channel in human small intestine
probably has interesting physiological as well as physiopatholog-
ical implications that remain to be clarified. The large activation
of this channel by point mutations may be associated with a
degenerin-like behavior as previously observed for channels
expressed in nematode mechanosensitive neurons. The hINaC
gene has been mapped on the 4q31.3^q32 region of the human
genome.
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1. Introduction
The amiloride-sensitive Na channel and degenerin family
(NaC/DEG) form a new family of cationic ion channels [1].
Members have been identi¢ed in many animal species ranging
from the nematode Caenorhabditis elegans to human [2]. In
C. elegans, neuronal and muscular degenerins are linked to
mechanotransduction [3] and the intestinal FLR-1 protein
controls the defecation rhythm [4]. The Drosophila dGNaC1
(also called ripped pocket) Na channel may play a role in
gametogenesis and early development [5,6] while the peptide
FMRFamide ionotropic receptor FaNaC is presumably in-
volved in neuronal modulations in the snail Helix aspersa
[7,8]. The mammalian NaC/DEG channels already identi¢ed
belong to two major groups. The ¢rst one includes the epi-
thelial Na channel ENaC associated with transepithelial Na
transport and Na homeostasis, as well as taste perception
[9,10]. The other group has been more recently discovered
and comprises the neuronal acid sensing ion channel (ASICs)
[1,11]. ASICs are external pH sensors present in brain and in
sensory neurons where they are thought to participate in no-
ciception associated with tissue acidosis, for instance in ische-
mic, damaged or in£amed tissue. Very recently, a novel re-
lated gene called BLINaC has been identi¢ed from rat and
mouse [12]. It is present principally in liver, intestine and
brain. BLINaC is only 30% identical to ASICs and is not
activated by an extracellular acidi¢cation, although it is able
to form an amiloride-sensitive Na-selective channel as re-
vealed by the introduction of gain-of-function mutations.
The physiological importance of NaC/DEG channels was
highlighted by the discovery of mutations in their genes that
are associated to genetic disorders. In human, mutations in
the K or L subunits of the epithelial Na channel are involved
in a hereditary form of human hypertension, the Liddle’s syn-
drome [13,14], while a loss-of-function of ENaC caused by
mutation on the K or L subunits are associated with pseudo-
hypoaldosteronism type 1, a disease characterized by severe
neonatal salt wasting with hyperkalaemic acidosis [15]. Muta-
tions in certain C. elegans degenerins lead to degeneration of
the expressing neurons (MEC-4 and DEG-1 [16,17]) or to
muscle hypercontraction (UNC-105 [18]). A constitutive acti-
vation of mammalian channels of the NaC/DEG family by
mutations equivalent to those occurring in C. elegans degen-
erins has been described [12,19] and leads to the death of the
expressing cells [19]. However, no association of such muta-
tions to genetic disorders has been described so far.
We describe here the molecular cloning, the functional ex-
pression and the chromosomal localization of a human ami-
loride-sensitive Na channel that is essentially expressed in
the small intestine. This channel is di¡erent from the already
cloned human NaC/DEG channels. It is constitutively acti-
vated by gain-of-function mutations and can be considered
as a novel human degenerin.
2. Materials and methods
2.1. Cloning of the hINaC gene
A human genomic library (2.5U106 clones; Clontech) was screened
with a 32P-labelled rat BLINaC cDNA probe corresponding to amino
acids 1^214 of hINaC. One positive clone was obtained, digested with
XhoI and subcloned into pBluescript SK3 vector (Stratagene). It con-
tained a 10 kb DNA insert which includes two exons corresponding to
amino acids 115^195 and 196^236 of hINaC. To identify the 3P end of
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the hINaC coding sequence, total RNA from human duodenum was
reverse-transcribed with superscript II reverse transcriptase (Gibco-
BRL) using the SP6/KS-oligo-dT primer (5P-GATTTAGGTGA-
CACTATAGAATCGAGGTCGACGGTATCCAGTCGAC(T)18-3P).
The RT sample was ampli¢ed by PCR (94‡C for 0.5 min, 60‡C for
0.5 min, 72‡C for 3 min; 43 cycles) using either the primer 5P-GATT-
TAGGTGACACTATAGAA-3P or 5P-TAGAATCGAGGTCGACG-
GTATC-3P, which are identical to parts of the SP6/KS-oligo-dT prim-
er, and one sense primer complementary to the hINaC coding
sequence (base position 510^531: 5P-ACTGATTTTGCTGCAAGT-
CACC-3P). To identify the 5P end of the hINaC coding sequence,
duodenum RNA was reverse-transcribed using oligo-(dT)15 primer
(Boehringer), poly G tailed with dGTP and terminal deoxynucleotidyl
transferase (Promega), and used for PCR. For the PCR (94‡C for
1 min, 45‡C for 1.5 min, 72‡C for 2.5 min; 10 cycles followed by
94‡C for 1 min, 55‡C for 1.5 min, 72‡C for 2.5 min; 41 cycles), two
primers (5P-CACTTGGAATTCGCGGCGTCA(C)18-3P and 5P-CAC-
TTGGAATTCGCGGCGTCA-3P) complementary to the tail and a
hINaC-speci¢c antisense primer (base position 531^510: 5P-GGTGA-
CTTGCAGCAAAATCAGT-3P) were simultaneously used. An addi-
tional PCR was performed (94‡C for 1 min, 55‡C for 1.5 min, 72‡C
for 2.5 min; 43 cycles) using one of the tail primers (5P-CAC-
TTGGAATTCGCGGCGTCA-3P) and a second hINaC antisense
primer (base position 287^265 5P-GATCTGCCATGTCACAAGTG-
AGA-3P). The PCR products were subcloned into pBluescript SK3
vector (Stratagene) and sequenced. These procedures allowed identi-
¢cation of the upstream of the ¢rst ATG codon and downstream of
the stop codon. The full-length hINaC coding sequence was recon-
structed from two overlapping PCR fragments located between a
sense primer positioned just before the ¢rst ATG (nucleotide positions
36^58: 5P-ACGCTAGCCTGAAATCACAAATGGAGCAGAC-3P)
and an anti-sense primer starting at nucleotide 1582 in the sequence
(5PGTGGATCCGGTATCATGAAAAGGAAACTATT-3P). The
cDNA was constructed in the Xenopus oocyte expression vector
pBSK-SP6-globin. The hINaC A443 mutants were prepared by
PCR using a modi¢cation of the method of gene splicing by overlap
extension [20].
2.2. Northern blot and RT-PCR
Human multiple tissue Northern blots containing about 2 Wg of
poly A RNA per lane were obtained from Clontech. The blots
were hybridized with a 32P-labeled hINaC 398 bp PCR fragment
corresponding to bases 390^758 for 16 h at 65‡C in the ExpressHyb
hybridization solution (Clontech), washed in 0.5USSC/0.1% SDS at
50‡C and subsequently exposed to Kodak X-Omat AR ¢lm for 17
days at 370‡C.
Two human multiple tissue cDNA (MTC) panels and a Human
Digestive System Panel (Clontech) was utilized as described by the
purchaser. Two primers (positions 442^464: 5P-GGCACATTG-
TATCCAAAGTCCTC-3P and positions 708^730: 5P-CCTCTTCCA-
GAGACACTCACTTT-3P) were used in a 20 Wl total reaction vol-
ume. Thirty high cycles of ampli¢cation (30 s at 95‡C, 1 min at 60‡C
and 1 min at 72‡C) for the MTC panel or 32 cycles of ampli¢cation
(30 s at 95‡C, 1 min at 55‡C and 1 min at 72‡C) for the human
digestive system panel were performed using Taq DNA polymerase
(Promega), except for GAPDH for which only 24 cycles were done.
One ¢fth of each PCR reaction was loaded on a 2% agarose gel and
than transferred onto nylon membrane (Hybond N, Amersham).
The membrane was hybridized with a 32P-labeled hINaC cDNA
probe, washed in 0.2USSC/0.1% SDS at 60‡C and then exposed to
Kodak X-Omat AR ¢lm at 370‡C.
2.3. Expression and electrophysiology in Xenopus oocytes
Isolation, maintenance and injection of stage V and VI Xenopus
oocytes with WT or mutated hINaC were performed as described
previously [21]. cRNA was synthesized from the NotI-digested
pBSK-SP6-globin hINaC vector using a kit from Stratagene. Xenopus
oocytes were injected with 0.25^10 ng of cRNA, and microelectrode
voltage-clamp assays were performed 1^3 days after injection. The
ND96 bathing solution contained (in mM): 96 NaCl, 2 KCl, 1 MgCl2,
1.8 CaCl2, 5 HEPES, pH 7.4 (with NaOH). In some experiments,
NaCl was replaced by KCl.
2.4. Fluorescent in situ hybridization (FISH) on the human genome
Metaphase spreads were prepared from phytohemagglutinin-stimu-
lated human lymphocytes cultured at 37‡C for 72 h. 5-Bromodeoxy-
uridine was added for the ¢nal 7 h of culture (60 Wg/ml of medium) to
ensure a chromosomal R-banding of good quality. The plasmid con-
taining the 10 kb genomic hINaC XhoI insert (see above) was bio-
tinylated by nick translation with biotin-16-dUTP, as outlined by the
Boehringer Mannheim protocol. Hybridization to chromosome
spreads was performed with a standard protocol [22]. For each slide,
200 ng of biotinylated DNA was used. Before hybridization, the la-
belled probe was annealed with a 150-fold excess amount of Cot-1
human DNA (Gibco-BRL) for 45 min at 37‡C to compete with the
non-speci¢c repetitive sequences. The hybridized probe was detected
by means of £uorescence isothiocyanate-conjugated avidin (Vector
laboratories). Chromosomes were counterstained and R-banded with
propidium iodide diluted in antifade solution (pH 11) as described in
Lemieux et al. [23].
3. Results
Screening of a human genomic library with a probe corre-
sponding to the rat BLINaC Na channel cDNA led to the
isolation of a partial genomic clone of 10 kb. Sequence com-
parison with the rat BLINaC cDNA suggested the presence of
two putative exons in this clone. The sequence of these puta-
tive exons was used to clone a full length cDNA from human
duodenum by 3P and 5P RACE-PCR. The cDNA is 1692 bp
long and contains an open reading frame preceded by one
stop codon and encodes a protein of 505 amino acids (Fig.
1A). This protein is 79% identical to rat and mouse BLINaC
(subsequently referred as rBLINaC and mBLINaC) (Fig. 1B).
The same identity (79%) was found at the nucleotide level.
The structure of the human protein is similar to that of rodent
BLINaC except for a small 10 amino acid extension at the
C-terminus. Assuming that the topology of the new protein is
similar to the proposed structure of related proteins of the
NaC/DEG family [24^26], the N-terminal intracellular region
contains three putative protein kinase C phosphorylation sites
and one potential casein kinase II phosphorylation site (Fig.
1A). The large extracellular loop contains eight putative
N-glycosylation sites.
A band of 2.1 kb was only detected by Northern blot on
human small intestine poly A RNA (Fig. 2A). No signal can
be detected on brain or on liver that has been shown to be the
major site of BLINaC expression in mouse [12]. The distribu-
tion of hINaC mRNA along the human digestive tract deter-
mined by RT-PCR con¢rmed its predominant expression in
the small intestine (duodenum and jejunum), a small signal
being detected in stomach, ileum and rectum (Fig. 2B). This
pattern is close to that found for rBLINaC or mBLINaC
except that a low and variable expression was also found in
rodent colon (not shown). A more sensitive detection of hI-
NaC mRNA by RT-PCR showed, in addition to a signal in
the small intestine, a weaker signal in testis while no signal
was detectable in the brain or in the liver even in PCR con-
ditions described to allow detection of rate transcripts (Fig.
2C).
The functional properties of hINaC have been analyzed
after expression of its complementary RNA into Xenopus oo-
cytes. A current of low amplitude (several tens of nA) that
does not discriminate between Na and K was recorded in
hINaC injected oocytes (not shown). This current is only par-
tially inhibited by 1 mM amiloride (not shown). A similar
type of current was also observed in rBLINaC injected oo-
cytes [12]. It is not clear at present if this current is related to
hINaC itself or to the non-speci¢c activation of some endog-
enous ion channel. However, it has been possible to obtain
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Fig. 1. Sequence of hINaC. A: The nucleotide sequence and the predicted protein sequence (505 amino acids) are shown. MI and MII corre-
spond to the two putative transmembrane domains, the ¢lled circles represent the putative protein kinase C phosphorylation sites, the ¢lled
square represents the putative casein kinase II phosphorylation site. Alanine 443 that when mutated leads to gain-of-function is marked by an
asterisk. The intron positions in the hINaC gene are marked with ¢lled triangles. The accession number for hINaC is AJ 252011. B: Phyloge-
netic analysis of several NaC/DEG family members isolated from Drosophila (dGNaC1, also named ripped pocket, and dmdNaC1, also named
pickpocket), C. elegans (including the degenerins MEC-10, MEC-4, DEG-1, UNC-8, and UNC-105), H. aspersa (the FMRFamide-activated
Na channel FaNaC) and mammals (including the human epithelial Na channel ENaC and the human ASICs). The hINaC protein is 79%
identical to mouse BLINaC and 29% identical to human ASICs. The tree was obtained using the GCG Distances program with Kimura substi-
tution followed by the GCG Growtree program with the UPGMA option, from an alignment generated with the GCG Pileup program.
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Fig. 2. Tissue distribution of hINaC. A: Northern blot analysis. A broad band of 2.1 kb was detected only on human small intestine poly A
RNA. B: The localization along the intestinal tract was assessed by RT-PCR using hINaC speci¢c primers (upper panel, Southern blot analysis
of the product of 32 cycles of ampli¢cation). A strong signal is detected in duodenum and jejunum and a weaker signal in stomach, ileum and
rectum, con¢rming the predominant expression of hINaC in the small intestine. Unlike in rat and mouse, no signal was detected in liver. C: A
more sensitive localization of hINaC mRNA in human tissues was obtained by RT-PCR (upper panel, negative image of an ethidium bromide
staining of the product of 38 cycles of ampli¢cation). The signi¢cant expression of hINaC in the small intestine was con¢rmed and a weak sig-
nal was also detected in testis, while no signal was detected in brain and in liver. The lower panel in B and C corresponds to a GAPDH ampli-
¢cation control (ethidium bromide staining for B and Southern blot analysis for C).
Fig. 3. Expression of hINaC in Xenopus oocytes. A: Wild-type hINaC or A443 mutant cRNAs have been injected into Xenopus oocytes (10 ng
per oocyte) and the amiloride-sensitive current (1 mM amiloride) was recorded at a holding potential of 370 mV 2 days later using the two-mi-
croelectrode voltage clamp. Expression of WT hINaC led to the appearance of a current of very low amplitude that is weakly sensitive to 1033
M amiloride and discriminates poorly between Na and K (not shown). The A443S mutant did not modify the amplitude of the current while
the A443C and particularly the A443F and the A443T mutants are associated to very large amiloride-sensitive currents of di¡erent properties.
The number of oocytes tested in each condition is given above the histograms. The control oocytes have been water-injected. A schematic rep-
resentation of the hINaC protein including the position of the gain-of-function mutations is shown below the histograms. Extracellular and in-
tracellular domains are referred to as out and in, respectively, and the two putative transmembrane domains as MI and MII. B: Dose^response
curves of the inhibition of the A443T gain-of-function mutant current recorded at 370 mV by amiloride and its derivatives benzamil and
EIPA. Each point represents the mean of 4^6 oocytes. The corresponding IC50 are 0.5 WM, 0.8 WM and 18 WM for amiloride, benzamil and
EIPA, respectively. C: Typical current^voltage relationship of the amiloride (1 mM)-sensitive current recorded from a representative oocyte ex-
pressing the A443T mutant in sodium-rich (ND96, 96 mM of external Na) or in potassium-rich (98 mM of external K) medium. The rever-
sal potential in ND96 medium is 35 mV.)
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very large activation of hINaC by mutating a particular res-
idue situated just before the second transmembrane domain
(TM2). Similar mutations are responsible for a gain-of-func-
tion when present in some C. elegans degenerins [16,17] and in
some mammalian NaC/DEG channels [12,19]. These muta-
tions consisted of the replacement of the alanine 443 of hI-
NaC by amino acids with larger side chains, such as cysteine,
phenylalanine or threonine. They led to a gain-of-function
associated to the appearance of large constitutive currents
(Fig. 3A). The current amplitude did not notably change for
the A443S mutation compared to the WT channel. However,
it signi¢cantly increases for the A443C mutant and raised to
several WA for the A443F and A443T mutants (Fig. 3A). The
properties of the A443T mutant have been analyzed in more
detail. The large decrease of the current after replacement of
external Na by K and the positive reversal potential in Na
rich medium (25 þ 6 mV, n = 5, Fig. 3C) provide evidence that
the gain-of-function mutant channel is highly selective for
Na ions. The current is reversibly blocked by the diuretic
amiloride (IC50 = 0.5 WM) and its derivatives benzamil
(IC50 = 0.8 WM) and EIPA (IC50 = 18 WM) (Fig. 3B).
The chromosomal localization of hINaC has been examined
by FISH (Fig. 4). A total of 30 metaphase cells was analyzed
and 90% of the cells showed speci¢c £uorescent spots on the
4q31.3^q32 region of the human genome (Fig. 4A,B). In ad-
dition, the intron/exon organization of the hINaC gene has
been deduced from the sequence of the partial genomic clone
initially isolated and from a human genomic sequence released
by the Whitehead Institute/MIT Center for Genome Research
(accession AC021433). The hINaC gene comprises at least 10
exons (Fig. 1A).
4. Discussion
A homology screening allowed the cloning in human of a
cDNA encoding a member of the amiloride-sensitive Na
channel and degenerin superfamily of ion channels. This sub-
unit is highly similar to a novel amiloride-sensitive Na chan-
nel that has been recently cloned from rodent [12]. hINaC
shares a lot of the properties previously described for rodent
BLINaC. Its sequence is close (79% identity) to that of rodent
BLINaC both at the amino acid and at the nucleotide level.
The hINaC gene is localized on chromosome 4 that is syntenic
to the mouse chromosome 3 where the mBLINaC gene is
located [12]. Both hINaC and BLINaC mRNAs are signi¢-
cantly expressed in the small intestine. Both channels are
activated by gain-of-function mutations and the mutated
channels have nearly identical electrophysiological and phar-
macological properties. hINaC is thus probably the ortholog
of the rodent BLINaC. However, some di¡erences exist. In
particular, no expression of hINaC has been detected in the
brain and in the liver, even by RT-PCR, while the liver is the
major site of mouse BLINaC expression.
The very large activity associated to the hINaC gain-of-
function mutants and the properties of these mutants (Na
selectivity, amiloride-sensitivity) suggest that this protein
forms a channel on its own that needs some activator to
open. The sequence and the structure of hINaC are close to
those of the ASICs (Fig. 1B) but hINaC is not a novel ASIC
since it is not activated by extracellular protons (not shown).
Phylogenetic analyses link hINaC to the group of ligand-
gated channels of the NaC/DEG family comprising ASICs
and FaNaC (Fig. 1B). An extracellular ligand, possibly a pep-
tide, is thus a possible candidate to activate hINaC. All the
putative ligand tested (e.g. FMRFamide and related mamma-
lian peptides) were without e¡ect on this channel (not shown).
The discovery of such a ligand, if it exists, will be a challeng-
ing task. A second essential task to elucidate the hINaC func-
tion is to determine the exact nature of the expressing cells.
This will require the development of dedicated tools like spe-
ci¢c antibodies directed against hINaC. There is no physio-
logical description in the small intestine of ion channels with
properties similar to those of hINaC. The small intestine has
been shown to display an amiloride-sensitive Na transport in
certain conditions like after proctocolectomy [27] but the
channel involved in that process appears to be the epithelial
Fig. 4. FISH mapping of the hINaC probe to human chromosome 4q31.3^q32. A: Metaphases observed with the large band FITC Zeiss ¢lter.
Chromosomes are stained with propidium iodide and the FITC £uorescent signal is shown on the ¢gure as white dots. B: Ideogram of the hu-
man G-banded chromosome 4 with the site of hybridization at 4q31^q32.
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Na channel ENaC. However, the properties of the native
hINaC are still unknown and can be signi¢cantly di¡erent
from those of the gain-of-function mutants described here,
even if the data obtained for the proton-gated channel ASI-
C2a suggests that the properties of gain-of-function mutants
of ASIC2a are not very di¡erent from those of the pH-acti-
vated channel [28].
Gain-of-function mutations in ion channels are often asso-
ciated to human pathologies [29]. The constitutive activation
of a Na-selective channel will undoubtedly lead to serious
damage in the expressing cells as previously described in vitro
[19]. This situation occurs in the nematode C. elegans where
mutations in the degenerins are responsible for neurodegener-
ation or muscle hypercontraction. The localization of hINaC
to the 4q31.3^q32 region of the human genome has not yet
revealed links to putative channelopathies but the speci¢c ex-
pression of this novel channel subunit in the human small
intestine will certainly gain the interest of pathologists work-
ing on intestinal diseases.
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